版本:
中国

BRIEF-Novelion Therapeutics reports Qtrly loss per share $1.67

May 9 Novelion Therapeutics Inc:

* Novelion Therapeutics reports first quarter 2017 financial results

* Sees FY 2017 revenue $155 million to $165 million

* Q1 revenue $30 million

* Qtrly loss per share $1.67

* Q1 earnings per share view $-0.45 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐